Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas

Human Pathology

Volumn 43, Issue 11, 2012, Pages 2012-2023

  Imamhasan, Abdukadir ^a,b   Mitomi, Hiroyuki ^a   Saito, Tsuyoshi ^a   Hayashi, Takuo ^a   Takahashi, Michiko ^a   Kajiyama, Yoshiaki ^a   Yao, Takashi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Basaloid squamous cell carcinoma; EGFR; Esophagus; Fluorescent in situ DNA hybridization; Mutation

Indexed keywords

BETA CATENIN; CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 903; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL FEATURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867871335     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.02.010     Document Type: Article

References (32)

1. S.L. Wain, R. Kier, R.T. Vollmer, and E.H. Bossen Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases Hum Pathol 17 1986 1158 1166
2. K. Abe, H. Sasano, Y. Itakura, T. Nishihira, S. Mori, and H. Nagura Basaloid-squamous carcinoma of the esophagus. A clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases Am J Surg Pathol 20 1996 453 461
3. M. Sarbia, P. Verreet, and F. Bittinger Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis Cancer 79 1997 1871 1878
4. N. Koide, S. Koike, W. Adachi, J. Amano, N. Usuda, and T. Nagata Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus Surg Today 27 1997 685 691
5. X.H. Zhang, G.Q. Sun, X.J. Zhou, H.F. Guo, and T.H. Zhang Basaloid squamous carcinoma of esophagus: a clinicopathological, immunohistochemical and electron microscopic study of sixteen cases World J Gastroenterol 4 1998 397 403
6. M. Sarbia, C. Loberg, and M. Wolter Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus Am J Pathol 155 1999 1027 1032
7. K.J. Cho, J.J. Jang, S.S. Lee, and J.I. Zo Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation Histopathology 36 2000 331 340
8. T. Owonikoko, C. Loberg, H.E. Gabbert, and M. Sarbia Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study J Pathol 193 2001 155 161
9. Z. Huang, Y. Shen, Y. Liang, and X. Wu Basaloid squamous cell carcinoma of the esophagus: an immunohistochemical study of 8 cases Chin Med J (Engl) 114 2001 1084 1088
10. K. Ohashi, S. Horiguchi, and S. Moriyama Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases Pathol Res Pract 199 2003 713 721
11. V.J. Amatya, Y. Takeshima, M. Kaneko, and K. Inai Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation Pathol Int 54 2004 803 809
12. A.M. Bellizzi, R.L. Woodford, C.A. Moskaluk, D.R. Jones, B.D. Kozower, and E.B. Stelow Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papilloma virus and related molecular markers Am J Surg Pathol 33 2009 1608 1614
13. Y. Kobayashi, Y. Nakanishi, and H. Taniguchi Histological diversity in basaloid squamous cell carcinoma of the esophagus Dis Esophagus 22 2009 231 238
14. M. Hanawa, S. Suzuki, and Y. Dobashi EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus Int J Cancer 118 2006 1173 1180
15. A. Imamhasan, H. Mitomi, T. Saito, A. Arakawa, and T. Yao Clear cell variant of squamous cell carcinoma originating in the esophagus: report of a case with immunohistochemical and oncogenetic analyses Pathol Int 62 2012 137 143
16. S.B. Chen, J.S. Yang, and W.P. Yang Treatment and prognosis of limited disease primary small cell carcinoma of esophagus Dis Esophagus 24 2011 114 119
17. G. Coggi, S. Bosari, and M. Roncalli p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations Cancer 79 1997 425 432
18. I. Sturm, H. Petrowsky, and R. Volz Analysis of p53/BAX/p16ink4a/CDKN2 in esophageal squamous cell carcinoma: high BAX and p16ink4a/CDKN2 identifies patients with good prognosis J Clin Oncol 19 2001 2272 2281
19. W.J. Nelson, and R. Nusse Convergence of Wnt, β-catenin, and cadherin pathways Science 303 2004 1483 1487
20. J. de Castro, C. Gamallo, and J. Palacios β-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome Virchows Arch 437 2000 599 604
21. J. Kudo, T. Nishiwaki, and N. Haruki Aberrant nuclear localization of β-catenin without genetic alterations in β-catenin or Axin genes in esophageal cancer World J Surg Oncol 5 2007 21
22. I. Ninomiya, Y. Endo, and S. Fushida Alteration of β-catenin expression in esophageal squamous-cell carcinoma Int J Cancer 85 2000 757 761
23. M.M. Mir, J.A. Dar, N.A. Dar, A.T. Syed, I. Salam, and G.N. Lone The Association of beta-catenin gene mutations and human papillomavirus in carcinoma of esophagus in a high-risk population of India Int J Health Sci (Qassim) 1 2007 177 183
24. P.A. Beachy, S.S. Karhadkar, and D.M. Berman Tissue repair and stem cell renewal in carcinogenesis Nature 432 2004 324 331
25. A. Wells EGF receptor Int J Biochem Cell Biol 31 1999 637 643
26. Y. Itakura, H. Sasano, and C. Shiga Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification Cancer 74 1994 795 804
27. L. Gibault, J.P. Metges, and V. Conan-Charlet Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer Br J Cancer 93 2005 107 115
28. M. Guo, S. Liu, and F. Lu Gefitinib-sensitizing mutations in esophageal carcinoma N Engl J Med 354 2006 2193 2194
29. Q.W. Liu, J.H. Fu, and K.J. Luo Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma Dis Esophagus 2011 10.1111/j.1442-2050.2010.01155.x [Epub ahead of print]
30. A. Mirza, M. Mustafa, E. Talevich, and N. Kannan Co-conserved features associated with cis regulation of ErbB tyrosine kinases PLoS One 5 2010 e14310
31. J.Y. Wu, J.Y. Shih, K.Y. Chen, C.H. Yang, C.J. Yu, and P.C. Yang Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Medicine (Baltimore) 90 2011 159 167
32. F. Hara, M. Aoe, and H. Doihara Antitumor effect of gefitinib (Iressa) on esophageal squamous cell carcinoma cell lines in vitro and in vivo Cancer Lett 226 2005 37 47